MSH|^~\&|HEXALIS|TEST|CERBA|EDS|20241023130841||ORU^R01^ORU_R01|202410231308411471|P|2.5.1|241023130841472||||FRA|8859/15|FR||05.00-104285^HEXALISPID|1||~275126322074974^^^ASIP-SANTE-INS-NIR&1.2.250.1.213.1.4.8&ISO^INS~C2091500011^^^HEXALIS&ETALON3_QUALIF500^LOCAL||ADRUNTESTCB^ZOE^^^ME^^D~ADRUN^ZOE^ZOE^^ME^^L|ADRUN|19751231|F|||^^^^^^^^63220||||||||||||MAZOIRES||1|||||||VALIZFD||||N|INSI|20220915164212|CNORC|SC|C2091600011_NA^HEXALIS^ETALON3_QUALIF500|C2091600011_NA^HEXALIS^ETALON3_QUALIF500|C2091600011-1-0011^HEXALIS^ETALON3_QUALIF500|CM||^^^20220916152900||20220916151900|||ZZESP^Dr ESSAYEDI PierreOBR|1|C2091600011_NA^HEXALIS^ETALON3_QUALIF500|C2091600011_NA^HEXALIS^ETALON3_QUALIF500|NA^SODIUM^HEXALIS-ETALON3_QUALIF500|||20220916152900|||||||20220916152900|||||||||||F|||||||||||20220916TQ1|||||||||ROBX|1|NM|NA--test^Sodium^HEXALIS-ETALON3_QUALIF500^NA^Sodium||140|mmol/L^^HEXALIS-ETALON3_QUALIF500|       135 Ã  145|N|||F|||20220916152005||JM^DR MARTIN Jean-Pierre